Skip to main content
Article
A preclinical model of CD38-pretargeted radioimmunotherapy for plasma cell malignancies.
Cancer Research (2014)
  • Damian J. Green, University of Washington
  • Nural N. Orgun, University of Washington
  • Jon C. Jones, University of Washington
  • Mark D. Hylarides, University of Washington
  • John M. Pagel, University of Washington
  • Donald K. Hamlin, University of Washington
  • D.S. Wilbur, University of Washington
  • Yukang Lin, University of Washington
  • Darrell R. Fisher, Pacific Northwest National Laboratory
  • Aimee L. Kenoyer, University of Washington
  • Shani L. Frayo, University of Washington
  • Ajay K. Gopal, University of Washington
  • Johnnie J. Orozco, University of Washington
  • Theodore A. Gooley, University of Washington
  • Brent L. Wood, University of Washington
  • William I. Bensinger, University of Washington
  • Oliver W. Press, University of Washington
Publication Date
February 15, 2014
DOI
10.1158/0008-5472.CAN-13-1589
Citation Information
Damian J. Green, Nural N. Orgun, Jon C. Jones, Mark D. Hylarides, et al.. "A preclinical model of CD38-pretargeted radioimmunotherapy for plasma cell malignancies." Cancer Research Vol. 74 Iss. 4 (2014) p. 1179 - 1189
Available at: http://works.bepress.com/john-pagel/104/